Senesco Technologies, Inc. (“Senesco” or the “Company”) (AMEX:SNT) announced today that its researchers will present two scientific abstracts at the 12th International Congress of Immunology and 4th Annual Congress of FOCIS to be held from July 18-23, 2004 at the Palais des Congres in Montreal, Quebec, Canada. Both abstracts will be presented at the Congress on Tuesday, July 20. These abstracts discuss the function of elf5A (“Factor 5A”), the gene underlying the Company’s proprietary technology, in the immune system and are as follows:
